European Society of Human Reproduction and Embryology High-risk Pregnancy and Patient Autonomy 2025

40 $

+ Include: 4 videos, size: 16.07 GB

+ Target Audience: reproductive endocrinologists/infertility specialists, maternal–fetal medicine and obstetrics teams, neonatologists, embryologists

Description

+ Include: 4 videos, size: 16.07 GB

+ Target Audience: reproductive endocrinologists/infertility specialists, maternal–fetal medicine and obstetrics teams, neonatologists, embryologists

+ Sample video: contact me for sample video

+ Information:

A multidisciplinary program exploring clinical, ethical, and communication challenges at the intersection of high-risk pregnancy and reproductive medicine. Faculty translate current evidence and policy into clear care pathways that respect patient autonomy while optimizing maternal–fetal outcomes.

What You Will Learn

  • Risk stratification for high-risk pregnancy in fertility patients (age, multiples, medical comorbidity, prior loss, ART-specific risks)

  • Shared decision-making frameworks that balance maternal preferences, fetal considerations, and guideline standards

  • Counseling for screening/diagnostics (NIPT, CVS, amniocentesis), prenatal imaging, and interpretation under uncertainty

  • Management of obstetric complications relevant to ART: hypertensive disorders, GDM, preterm birth, placenta previa/accreta, growth restriction, multiples reduction

  • Ethics & law: consent, refusal of care, confidentiality, neonatal thresholds, and cross-border considerations

  • Communication in complex scenarios: values clarification, interpreter use, decisional capacity, conflict resolution

  • Perinatal palliative options, psychosocial support, and trauma-informed care

  • Postpartum follow-up after high-risk pregnancy: cardiometabolic risk, contraception, interpregnancy planning, and fertility counseling

Event Details

  • Format: Live, case-based lectures, debates, and interactive workshops

  • Structure: Clinical risk → Diagnostics & counseling → Complications & pathways → Ethics & law → Communication & follow-up

  • Takeaways: Checklists, counseling scripts, and decision aids suitable for clinic and MDT use

Who Should Attend
Reproductive endocrinologists/infertility specialists, maternal–fetal medicine and obstetrics teams, neonatologists, genetic counselors, embryologists, midwives/nurses, psychologists, ethicists, patient advocates, and trainees.

Why Attend

  • Convert evolving evidence and policy into repeatable, autonomy-respecting workflows

  • Improve counseling quality and documentation for high-stakes decisions

  • Strengthen collaboration across fertility, obstetric, neonatal, and ethics teams

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the section below

  • Preconception optimization after ART; single-embryo transfer and multiple-gestation risk

  • Prenatal screening/diagnosis: indications, limitations, residual risk, and consent essentials

  • Hypertension, GDM, thyroid disease, thrombophilia, and cardiac disease in pregnancy

  • Preterm-birth prevention and cervical strategies; steroid and magnesium protocols

  • Placental disorders and hemorrhage risk: imaging, referral timing, delivery planning

  • Fetal growth restriction & Doppler surveillance; timing of delivery and escalation

  • Multifetal pregnancy reduction: ethics, counseling, and procedural considerations

  • Autonomy vs. beneficence tensions: refusal of recommended care, safeguarding, and documentation

  • Perinatal palliative care; bereavement and mental-health pathways

  • Postpartum cardiometabolic follow-up, lactation with comorbidities, contraception after high-risk pregnancy

Reviews

There are no reviews yet.

Be the first to review “European Society of Human Reproduction and Embryology High-risk Pregnancy and Patient Autonomy 2025”

Your email address will not be published. Required fields are marked *

67 − 66 =
Powered by MathCaptcha